GenomeWeb
@genomeweb.bsky.social
Highlighting the best of GenomeWeb's coverage of genomics, diagnostics, and precision medicine. Read the latest news at genomeweb.com.
CRISPR Therapeutics' ANGPTL3-targeting therapy show durable lipid reductions and safety, according to early Phase Ib data from an ongoing trial presented at the AHA Scientific Sessions.
CRISPR Therapeutics’ Gene Editor Shows Promise in Early-Stage Severe Hypertriglyceridemia Trial
CRISPR Therapeutics’ Gene Editor Shows Promise in Early-Stage Severe Hypertriglyceridemia Trial
ebx.sh
The Bay Area startup, which came out of stealth mode last month, has exclusively licensed its foundation technology, called expo-Archive, from Hanlee Ji's lab at Stanford University.
Exponential Molecular Turns Precious DNA Samples Into Resources That Don’t Deplete
Exponential Molecular Turns Precious DNA Samples Into Resources That Don’t Deplete
ebx.sh
MD Anderson experts outlined the institution's evolving approach to KRAS mutation testing and highlighted challenges remaining for liquid and tissue testing in pancreatic cancer.
AMP Experts Outline Evolving KRAS Testing Workflows as Targeted Therapies Expand
AMP Experts Outline Evolving KRAS Testing Workflows as Targeted Therapies Expand
ebx.sh
At the AMP annual meeting in Seattle, a lab manager for ACH said the new assay addresses a "critical diagnostic gap" for assessing and controlling measles outbreaks.
Arkansas Children’s Hospital Develops Molecular Measles Dx, Typing Test Using Bruker ASRs
Arkansas Children’s Hospital Develops Molecular Measles Dx, Typing Test Using Bruker ASRs
ebx.sh
CRISPR Therapeutics' ANGPTL3-targeting therapy show durable lipid reductions and safety, according to early Phase Ib data from an ongoing trial presented at the AHA Scientific Sessions.
CRISPR Therapeutics’ Gene Editor Shows Promise in Early-Stage Severe Hypertriglyceridemia Trial
CRISPR Therapeutics’ Gene Editor Shows Promise in Early-Stage Severe Hypertriglyceridemia Trial
ebx.sh
The RT-PCR assay is the first FDA-cleared product for the Birmingham, Alabama-based company.
Molecular Designs Gets FDA Clearance for Flu, RSV Assay
Molecular Designs Gets FDA Clearance for Flu, RSV Assay
ebx.sh
A retrospective study showed that rapid whole-genome sequencing identified diagnostic findings in about a third of adolescents tested at the hospital between 2021 and 2025.
Rady Children’s Lab Director Makes Case at AMP for Rapid WGS in Adolescents for Genetic Disease Dx
Rady Children’s Lab Director Makes Case at AMP for Rapid WGS in Adolescents for Genetic Disease Dx
ebx.sh
News items for the week of November 9, 2026: Color Health, Yourgene Health, Fauna Bio, Helix, BioMap, Artera, AbelZeta, Vittoria Biotherapeutics
In Brief This Week: Color, Yourgene, Fauna, Helix, BioMap, Artera, AbelZeta, Vittoria, Quest
In Brief This Week: Color, Yourgene, Fauna, Helix, BioMap, Artera, AbelZeta, Vittoria, Quest
ebx.sh
Pharmacogene variants were present across the board in an analysis of almost 100,000 All of Us participants, highlighting the potential clinical utility of genetics-informed prescribing.
Widespread Pharmacogenomic Variation in Diverse All of Us Cohort Bolsters Case for Genetics-Guided Prescribing
Widespread Pharmacogenomic Variation in Diverse All of Us Cohort Bolsters Case for Genetics-Guided Prescribing
ebx.sh
The funding will support microbiome and genomics research using artificial intelligence to discover new personalized therapies.
City of Hope Boosting Precision Oncology Ambitions With $11M Gift
City of Hope Boosting Precision Oncology Ambitions With $11M Gift
ebx.sh
The firm is evaluating CITY-RBP4, an siRNA therapy designed to silence RBP4 expression, in a Phase I trial expected to initially read out in mid-2027.
City Therapeutics Launches Trial of RNAi Therapy for Stargardt Disease
City Therapeutics Launches Trial of RNAi Therapy for Stargardt Disease
ebx.sh
Researchers put together an atlas of features found in "stage 0" ductal carcinoma in situ, comparing them to those of invasive breast cancers.
Preinvasive Breast Cancer Single-Cell Study Reveals Microenvironment Changes
Preinvasive Breast Cancer Single-Cell Study Reveals Microenvironment Changes
ebx.sh
The Bay Area startup, which came out of stealth mode last month, has exclusively licensed its foundation technology, called expo-Archive, from Hanlee Ji's lab at Stanford University.
Exponential Molecular Turns Precious DNA Samples Into Resources That Don’t Deplete
Exponential Molecular Turns Precious DNA Samples Into Resources That Don’t Deplete
ebx.sh
The firm split its sales and marketing functions and said it has made considerable progress in backfilling and rebuilding its sales team.
Mdxhealth Restructures Business as Q3 Revenue Remains Flat
Mdxhealth Restructures Business as Q3 Revenue Remains Flat
ebx.sh
The masterplan wants to extend the Emirati Genome Program to all citizens, provide personalized genomic reports to 900,000 participants, and expand newborn genetic screening.
UAE Genomics Masterplan to Shift Focus From Data Collection to Healthcare Implementation
UAE Genomics Masterplan to Shift Focus From Data Collection to Healthcare Implementation
ebx.sh
The financing will support a new design and testing facility in Vilnius, Lithuania, where the company is located.
Enzyme Design Firm Biomatter Raises $18M in Series A Round
Enzyme Design Firm Biomatter Raises $18M in Series A Round
genomeweb.com
The prospective study aims to enroll 300 patients to evaluate whether the ChromoSeq test can replace conventional cytogenetics, FISH and targeted NGS testing.
Caris Life Sciences Kicks Off Multicenter Study to Evaluate WGS Assay for Myeloid Malignancies
Caris Life Sciences Kicks Off Multicenter Study to Evaluate WGS Assay for Myeloid Malignancies
ebx.sh
23andMe will help recruit participants for SRTI's Wellderly Brain Study, which will investigate whether lifestyle modifications can alter Alzheimer's-related biological pathways.
23andMe Research Institute, Scripps Team up for Alzheimer’s Study Recruitment
23andMe Research Institute, Scripps Team up for Alzheimer’s Study Recruitment
ebx.sh
At the AMP annual meeting, Roche emphasized the increasing importance of HLA genotyping for clinical trial enrollment and treatment selection.
Roche Adds HLA Typing to CGP Assay, Anticipating Growing Utility in Cancer Treatment Selection
Roche Adds HLA Typing to CGP Assay, Anticipating Growing Utility in Cancer Treatment Selection
ebx.sh
The modified LDT based on Thermo Fisher's Oncomine Precision Assay is designed to help physicians better customize therapeutic plans.
Roswell Park Details PGx Add-ons to Thermo Fisher Cancer Panel at AMP; Nabs NYS Approval
Roswell Park Details PGx Add-ons to Thermo Fisher Cancer Panel at AMP; Nabs NYS Approval
ebx.sh
The rule, which moves these tests off the CLFS, impacts reimbursement starting in 2027 while raising longer-term questions around issues like test regulation and classification.
CMS Rule on Reimbursement of Algorithm-Only Tests Raises Concerns, Uncertainty
CMS Rule on Reimbursement of Algorithm-Only Tests Raises Concerns, Uncertainty
ebx.sh
The controversial program sped up review to just a few months for some drugmakers with therapy programs that aligned with US national interests.
FDA Reportedly Drops Commissioner’s National Priority Voucher Program
FDA Reportedly Drops Commissioner’s National Priority Voucher Program
ebx.sh
Under the non-exclusive agreement, the firms will combine Ascidian's RNA exon editing technology with Exegenesis Bio's AAV capsid engineering expertise.
Ascidian, Exegenesis Bio to Collaborate on Therapeutic RNA Exon Editors
Ascidian, Exegenesis Bio to Collaborate on Therapeutic RNA Exon Editors
ebx.sh
In more than 20 papers, BICAN researchers dug into the structure, molecular processes, and cellular makeup of basal ganglia, a brain region important for motor control and several neurological diseases.
BRAIN Initiative Cell Atlas Network Maps Basal Ganglia in Mammalian Brains
BRAIN Initiative Cell Atlas Network Maps Basal Ganglia in Mammalian Brains
ebx.sh
The company is dropping a CAR T-cell therapy that used its whole blood rapid manufacturing process, suggesting that it can already broaden access through miv-cel.
Kyverna Completes BLA Submission for Autoimmune CAR T, Abandons Another
Kyverna Completes BLA Submission for Autoimmune CAR T, Abandons Another
ebx.sh
The Clear Dx instrument now features automated workflows integrating Promega's Maxwell HT chemistries and PGDx's elio tissue complete panel.
At AMP, Clear Labs Details Collaborations to Expand Uses For Clear Dx Automation Platform
At AMP, Clear Labs Details Collaborations to Expand Uses For Clear Dx Automation Platform
ebx.sh
According to the suit, Waters' forthcoming BD FACS360 Sample Preparation System was developed using trade secrets underpinning Curiox's Pluto system.
Curiox Biosystems Sues Waters, BD Over Flow Cytometry Tech Trade Secrets
Curiox Biosystems Sues Waters, BD Over Flow Cytometry Tech Trade Secrets
ebx.sh
The firm made a deal with Hebei Senlang Biotechnology in September and is now licensing the platform and a therapy.
Tempest Licenses Global Rights to Chinese Biotech’s In Vivo CAR Platform
Tempest Licenses Global Rights to Chinese Biotech’s In Vivo CAR Platform
ebx.sh
Pharmacogene variants were present across the board in an analysis of almost 100,000 All of Us participants, highlighting the potential clinical utility of genetics-informed prescribing.
Widespread Pharmacogenomic Variation in Diverse All of Us Cohort Bolsters Case for Genetics-Guided Prescribing
Widespread Pharmacogenomic Variation in Diverse All of Us Cohort Bolsters Case for Genetics-Guided Prescribing
ebx.sh
AI drug discovery revenue was $59.1 million in fiscal year 2026, and the company expects $100 million for this business segment in fiscal year 2027.
Twist Projects Revenue Boost for FY2027 as AI Business Sees Triple-Digit Growth in FY2026
Twist Projects Revenue Boost for FY2027 as AI Business Sees Triple-Digit Growth in FY2026
ebx.sh